Bullock Wealth Management Group »

Vaneck Vectors Pharmaceutical etf shares owned by Bullock Wealth Management Group

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Bullock Wealth Management Group from 13F filings

Historical chart of Bullock Wealth Management Group investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Bullock Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Bullock Wealth Management Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.9k 85 104.64

More positions owned by Bullock Wealth Management Group

Pacer Trendpilot Us Large Cap Etf Etf (PTLC)
Nvidia Corporation Stock (NVDA)
Pacer Trendpilot 100 Etf Etf (PTNQ)
Pacer Trendpilot International Etf Etf (PTIN)
Pacer Trendpilot Us Mid Cap Etf Etf (PTMC)
Microsoft Corp Stock (MSFT)
Pacer Us Cash Cows 100 Etf Etf (COWZ)
Apple Stock (AAPL)
Eli Lilly & Co Stock (LLY)
Invesco S&p 500 Equal Weight Technology Etf Etf (RSPT)
Dimensional Ultrashort Fixed Income Etf Etf (DUSB)
Caterpillar Stock (CAT)
State Street Communication Services Select Sector Spdr Etf Etf (XLC)
Broadcom Stock (AVGO)
Jpmorgan Chase & Co Stock (JPM)

View all positions for Bullock Wealth Management Group

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
UBS Group
Healthcare Of Ontario Pension Plan Trust Fund
Bnp Paribas Arbitrage, Snc
J.Safra Asset Management
Susquehanna International
Avalon Trust
Citigroup
Morgan Stanley
Adamsbrown Wealth Consultants
LPL Financial
Miller Investment Management
Royal Bank of Canada
Bank of America Corporation
Rye Brook Capital

View all funds holding Vaneck Vectors Pharmaceutical etf